Neuroscience
Major Depressive Disorder
100%
Bipolar Disorder
75%
Brain
55%
Antidepressant
42%
Cortisol
32%
Treatment-Resistant Depression
25%
Mood Disorder
22%
Randomized Controlled Trial
14%
Behavior (Neuroscience)
13%
Emotion
13%
Anxiety
13%
Cognitive Disorders
13%
Glucocorticoid Receptor
12%
Psychiatry
11%
Pediatric Trauma
10%
Prefrontal Cortex
9%
Amygdala
9%
Temporal Lobe
9%
Cognition
9%
Antipsychotic
8%
Glucocorticoid
8%
Ketamine
7%
C-Reactive Protein
6%
Depression
6%
Minocycline
6%
Interleukin 6
6%
Treatment of Depression
6%
Hippocampus
6%
Dopamine
6%
Cingulate Cortex
6%
Anti-Inflammatory
5%
Mental Disorder
5%
Omega 3 Fatty Acid
5%
Quetiapine
5%
Obsessive-Compulsive Disorder
5%
Genotype
5%
Psychotherapy
5%
Interferon
5%
Attention Deficit Hyperactivity Disorder
5%
Medicine and Dentistry
Therapeutic Procedure
68%
Patient
60%
Major Depressive Episode
30%
Systematic Review
22%
Depression
21%
Symptom
20%
Disease
16%
Treatment Resistant Depression
16%
Hydrocortisone
16%
Randomized Controlled Trial
15%
Diagnosis
14%
Association
14%
Mental Health
14%
Primary Health Care
14%
Meta-Analysis
14%
Woman
11%
Health
11%
Analysis
9%
Inflammation
9%
Anxiety
8%
Drug Therapy
8%
Consensus
8%
Adult
8%
Experience
7%
Follow up
7%
Age
7%
Biological Marker
7%
Psychosis
7%
Stress
6%
Child
6%
Marker
6%
Mood
5%
Minocycline
5%
Spontaneous Remission
5%
Childhood
5%
Psychology
Bipolar Disorder
50%
Systematic Review
35%
Depression
29%
Meta-Analysis
26%
Mental Health
24%
Anxiety
23%
Schizophrenia
17%
Mood Disorder
16%
Major Depression
13%
Mood
13%
Emotion
12%
Functional Magnetic Resonance Imaging
10%
Quality
10%
Bipolar Depression
8%
Mental Illness
8%
Quality of Life
7%
Coronary Heart Disease
7%
Infant
6%
Clinical Trial
6%
Attention
6%
Cognitive Impairment
6%
Psychiatric Disorder
6%
Vulnerability
6%
Cognition
6%
Healthcare
6%
Cognitive Behavioral Therapy
6%
Anxiety Disorder
6%
Psychotic Disorder
6%
Posttraumatic Stress Disorder
5%
Psychotherapy
5%
Specificity
5%
Comorbidity
5%
Fear
5%
Cortex
5%
Practitioners
5%